Judge Jones Kicks out ID

Judge John E. Jones III ruled that the mention of Intelligent Design in Dover area high schools as an alternative to evolution was not only unconstitutional but unscientific. In the final days of the case it appeared more and more apparent that the judge was less than impressed by the arguments of the defendants as they bumblingly tried to cover their motivation for injecting ID into the schools. But Jones? ruling really takes the whole ID hypothesis to task as a blatant and undeniable extensio

Written byBrendan Maher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Judge John E. Jones III ruled that the mention of Intelligent Design in Dover area high schools as an alternative to evolution was not only unconstitutional but unscientific. In the final days of the case it appeared more and more apparent that the judge was less than impressed by the arguments of the defendants as they bumblingly tried to cover their motivation for injecting ID into the schools. But Jones? ruling really takes the whole ID hypothesis to task as a blatant and undeniable extension of creation science masked by new pseudoscientific verbiage.Scanning the 140 page document turns up the following:
After a searching review of the record and applicable case law, we find that while ID arguments may be true, a proposition on which the Court takes no position, ID is not science. We find that ID fails on three different levels, any one of which is sufficient to preclude a determination that ID is science. They are: (1) ID violates the centuries-old ground rules of science by invoking and permitting supernatural causation; (2) the argument of irreducible complexity, central to ID, employs the same flawed and illogical contrived dualism that doomed creation science in the 1980's; and (3) ID?s negative attacks on evolution have been refuted by the scientific community. As we will discuss in more detail below, it is additionally important to note that ID has failed to gain acceptance in the scientific community, it has not generated peer-reviewed publications, nor has it been the subject of testing and research.
The decision could dissuade other communities from trying to introduce ID. The board members elected this November (largely on a platform not supporting ID) will not likely pursue an appeal on the decision, so the case will not likely go to the Supreme Court. They may, however, be stuck with the >$1 million price tag for the plaintiffs? attorneys. Certainly the effects on the nearly 4,000 Dover area students will be felt in more than their science classes. Judge Jones?s conclusion carried this admonition:
The breathtaking inanity of the Board?s decision is evident when considered against the factual backdrop which has now been fully revealed through this trial. The students, parents, and teachers of the Dover Area School District deserved better than to be dragged into this legal maelstrom, with its resulting utter waste of monetary and personal resources.
Let?s hope this lesson serves well.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies